BOSTON--(BUSINESS WIRE)--Strand Therapeutics, the world’s first programmable mRNA company developing curative therapies for cancer, autoimmune diseases, and beyond, today announced the first patient ...
As a grad student in biological engineering at MIT, Jake Becraft had an idea that could change the way we treat cancer: What if genes could be turned on and off like light switches? Thinking it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback